Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Return on Assets (2016 - 2025)

Historic Return on Assets for Neurocrine Biosciences (NBIX) over the last 14 years, with Q4 2025 value amounting to 0.11%.

  • Neurocrine Biosciences' Return on Assets rose 100.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.11%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.11% for FY2025, which is 200.0% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Return on Assets of 0.11% as of Q4 2025, which was up 100.0% from 0.1% recorded in Q3 2025.
  • Over the past 5 years, Neurocrine Biosciences' Return on Assets peaked at 0.11% during Q3 2024, and registered a low of 0.01% during Q2 2021.
  • In the last 4 years, Neurocrine Biosciences' Return on Assets had a median value of 0.08% in 2025 and averaged 0.07%.
  • In the last 5 years, Neurocrine Biosciences' Return on Assets tumbled by -1300bps in 2021 and then skyrocketed by 1000bps in 2024.
  • Quarter analysis of 4 years shows Neurocrine Biosciences' Return on Assets stood at 0.05% in 2021, then skyrocketed by 68bps to 0.08% in 2023, then increased by 15bps to 0.09% in 2024, then rose by 14bps to 0.11% in 2025.
  • Its Return on Assets stands at 0.11% for Q4 2025, versus 0.1% for Q3 2025 and 0.09% for Q2 2025.